Literature DB >> 17307135

Amyloid-linked cellular toxicity triggered by bacterial inclusion bodies.

Nuria González-Montalbán1, Antonio Villaverde, Anna Aris.   

Abstract

The aggregation of proteins in the form of amyloid fibrils and plaques is the characteristic feature of some pathological conditions ranging from neurodegenerative disorders to systemic amyloidoses. The mechanisms by which the aggregation processes result in cell damage are under intense investigation but recent data indicate that prefibrillar aggregates are the most proximate mediators of toxicity rather than mature fibrils. Since it has been shown that prefibrillar forms of the nondisease-related misfolded proteins are highly toxic to cultured mammalian cells we have studied the cytoxicity associated to bacterial inclusion bodies that have been recently described as protein deposits presenting amyloid-like structures. We have proved that bacterial inclusion bodies composed by a misfolding-prone beta-galactosidase fusion protein are clearly toxic for mammalian cells but the beta-galactosidase wild type enzyme forming more structured thermal aggregates does not impair cell viability, despite it also binds and enter into the cells. These results are in the line that the most cytotoxic aggregates are early prefibrilar assemblies but discard the hypothesis that the membrane destabilization is the key event to subsequent disruption of cellular processes, such as ion balance, oxidative state and the eventually cell death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307135     DOI: 10.1016/j.bbrc.2007.01.192

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Towards revealing the structure of bacterial inclusion bodies.

Authors:  Lei Wang
Journal:  Prion       Date:  2009-07-25       Impact factor: 3.931

2.  Amyloid-like protein inclusions in tobacco transgenic plants.

Authors:  Anna Villar-Piqué; Raimon Sabaté; Oriol Lopera; Jordi Gibert; Josep Maria Torne; Mireya Santos; Salvador Ventura
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

3.  In-cell aggregation of a polyglutamine-containing chimera is a multistep process initiated by the flanking sequence.

Authors:  Zoya Ignatova; Ashwani K Thakur; Ronald Wetzel; Lila M Gierasch
Journal:  J Biol Chem       Date:  2007-10-17       Impact factor: 5.157

4.  Modeling amyloids in bacteria.

Authors:  Anna Villar-Piqué; Salvador Ventura
Journal:  Microb Cell Fact       Date:  2012-12-28       Impact factor: 5.328

5.  Packaging protein drugs as bacterial inclusion bodies for therapeutic applications.

Authors:  Antonio Villaverde; Elena García-Fruitós; Ursula Rinas; Joaquin Seras-Franzoso; Ana Kosoy; José Luis Corchero; Esther Vazquez
Journal:  Microb Cell Fact       Date:  2012-06-11       Impact factor: 5.328

6.  Bacterial inclusion bodies contain amyloid-like structure.

Authors:  Lei Wang; Samir K Maji; Michael R Sawaya; David Eisenberg; Roland Riek
Journal:  PLoS Biol       Date:  2008-08-05       Impact factor: 8.029

7.  Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste.

Authors:  Ugutz Unzueta; Julieta M Sanchez; Elena Garcia-Fruitós; Joaquin Seras-Franzoso
Journal:  Front Bioeng Biotechnol       Date:  2022-09-05

8.  A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.

Authors:  Antonios C Tsolis; Nikos C Papandreou; Vassiliki A Iconomidou; Stavros J Hamodrakas
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.